Rakuten Medical Announces Recent Interim Data from Phase 1b/2 Clinical Trial of ASP-1929 Photoimmunotherapy in Combination with anti-PD-1 for First Line Recurrent and/or Metastatic Head and Neck Cancer to be Presented at ASCO 2024

Overall survival rate estimated at 24 months was 52.4% with generally tolerated safety profile Completed a…

Continue Reading

Transforming Clinical Quality & Value in Rehabilitation with Neurocognitive Technology

The following is a guest article by Jared Gillespie, Senior Director of Clinical Solutions at Academy…

Continue Reading

Microsoft, Nuance announce clinical notes application powered by GPT4

Velib bicycles are parked in front of the the U.S. computer and micro-computing company headquarters Microsoft…

Continue Reading

MHRA to streamline clinical trial approvals in biggest overhaul of trial regulation in 20 years

A series of new measures will be introduced by the Medicines and Healthcare products Regulatory Agency…

Continue Reading

Oral cancer task force’s guidelines for Head & Neck cancer recognised among 13 worldwide clinical practice guidelines – News Healthcare

The Consensus Guidelines for the Management of Head and Neck Cancer (HNC), developed under the aegis…

Continue Reading

Revolutionizing healthcare: the role of artificial intelligence in clinical practice | BMC Medical Education

Suleimenov IE, Vitulyova YS, Bakirov AS, Gabrielyan OA. Artificial Intelligence:what is it? Proc 2020 6th Int…

Continue Reading